Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1986 1
1990 1
1994 3
1995 1
1996 1
1997 2
1998 1
1999 1
2000 4
2001 3
2002 2
2003 3
2004 2
2005 1
2006 1
2007 4
2008 3
2009 5
2010 4
2011 5
2012 9
2013 9
2014 10
2015 10
2016 9
2017 2
2018 10
2019 16
2020 19
2021 23
2022 17
2023 19
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

194 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.
Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, Haanpää M, Hansson P, Jensen TS, Kamerman PR, Lund K, Moore A, Raja SN, Rice AS, Rowbotham M, Sena E, Siddall P, Smith BH, Wallace M. Finnerup NB, et al. Lancet Neurol. 2015 Feb;14(2):162-73. doi: 10.1016/S1474-4422(14)70251-0. Epub 2015 Jan 7. Lancet Neurol. 2015. PMID: 25575710 Free PMC article. Review.
Chronic Kidney Disease and Cerebrovascular Disease: Consensus and Guidance From a KDIGO Controversies Conference.
Kelly DM, Ademi Z, Doehner W, Lip GYH, Mark P, Toyoda K, Wong CX, Sarnak M, Cheung M, Herzog CA, Johansen KL, Reinecke H, Sood MM. Kelly DM, et al. Stroke. 2021 Jul;52(7):e328-e346. doi: 10.1161/STROKEAHA.120.029680. Epub 2021 Jun 3. Stroke. 2021. PMID: 34078109 Free article. Review.
Proposed underlying mechanisms for this relationship include shared traditional risk factors such as hypertension and diabetes, uremia-related nontraditional risk factors, such as oxidative stress and abnormal calcium-phosphorus metabolism, and dialysis-specific factors su …
Proposed underlying mechanisms for this relationship include shared traditional risk factors such as hypertension and diabetes, uremi …
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.
Piccoli L, Park YJ, Tortorici MA, Czudnochowski N, Walls AC, Beltramello M, Silacci-Fregni C, Pinto D, Rosen LE, Bowen JE, Acton OJ, Jaconi S, Guarino B, Minola A, Zatta F, Sprugasci N, Bassi J, Peter A, De Marco A, Nix JC, Mele F, Jovic S, Rodriguez BF, Gupta SV, Jin F, Piumatti G, Lo Presti G, Pellanda AF, Biggiogero M, Tarkowski M, Pizzuto MS, Cameroni E, Havenar-Daughton C, Smithey M, Hong D, Lepori V, Albanese E, Ceschi A, Bernasconi E, Elzi L, Ferrari P, Garzoni C, Riva A, Snell G, Sallusto F, Fink K, Virgin HW, Lanzavecchia A, Corti D, Veesler D. Piccoli L, et al. Cell. 2020 Nov 12;183(4):1024-1042.e21. doi: 10.1016/j.cell.2020.09.037. Epub 2020 Sep 16. Cell. 2020. PMID: 32991844 Free PMC article.
Clinical Management of Moyamoya Patients.
Canavero I, Vetrano IG, Zedde M, Pascarella R, Gatti L, Acerbi F, Nava S, Ferroli P, Parati EA, Bersano A. Canavero I, et al. J Clin Med. 2021 Aug 17;10(16):3628. doi: 10.3390/jcm10163628. J Clin Med. 2021. PMID: 34441923 Free PMC article. Review.
MMA is often idiopathic (moyamoya disease-MMD); conversely, it can be associated with acquired or hereditary conditions (moyamoya Syndrome-MMS); however, the pathophysiology underlying either MMD or MMS has not been fully elucidated to date, and this poor knowledge …
MMA is often idiopathic (moyamoya disease-MMD); conversely, it can be associated with acquired or hereditary conditions (moyamoya Syndrome- …
Standard metadata for 3D microscopy.
Ropelewski AJ, Rizzo MA, Swedlow JR, Huisken J, Osten P, Khanjani N, Weiss K, Bakalov V, Engle M, Gridley L, Krzyzanowski M, Madden T, Maiese D, Mandal M, Waterfield J, Williams D, Hamilton CM, Huggins W. Ropelewski AJ, et al. Sci Data. 2022 Jul 27;9(1):449. doi: 10.1038/s41597-022-01562-5. Sci Data. 2022. PMID: 35896564 Free PMC article.
These standards were built on existing efforts and developed with input from the brain microscopy community to promote adoption. The resulting 3D Microscopy Metadata Standards (3D-MMS) includes 91 fields organized into seven categories: Contributors, Funders, Publication, …
These standards were built on existing efforts and developed with input from the brain microscopy community to promote adoption. The resulti …
A Review of Mobile Mapping Systems: From Sensors to Applications.
Elhashash M, Albanwan H, Qin R. Elhashash M, et al. Sensors (Basel). 2022 Jun 2;22(11):4262. doi: 10.3390/s22114262. Sensors (Basel). 2022. PMID: 35684883 Free PMC article. Review.
In this paper, we presented a comprehensive review of the modern MMSs by focusing on: (1) the types of sensors and platforms, discussing their capabilities and limitations and providing a comprehensive overview of recent MMS technologies available in the market; (2) highli …
In this paper, we presented a comprehensive review of the modern MMSs by focusing on: (1) the types of sensors and platforms, discussing the …
Serum metabolomics of treatment response in myasthenia gravis.
Sikorski P, Li Y, Cheema M, Wolfe GI, Kusner LL, Aban I, Kaminski HJ. Sikorski P, et al. PLoS One. 2023 Oct 10;18(10):e0287654. doi: 10.1371/journal.pone.0287654. eCollection 2023. PLoS One. 2023. PMID: 37816000 Free PMC article. Clinical Trial.
Treatment response was assessed using validated outcome measures of minimal manifestation status (MMS), MG-Activities of Daily Living (MG-ADL), Quantitative MG (QMG) score, or a strictly defined composite measure of response. RESULTS: Increased serum levels of phospholipid …
Treatment response was assessed using validated outcome measures of minimal manifestation status (MMS), MG-Activities of Daily Living …
Noble Metal Nanoparticle Biosensors: From Fundamental Studies toward Point-of-Care Diagnostics.
Geng H, Vilms Pedersen S, Ma Y, Haghighi T, Dai H, Howes PD, Stevens MM. Geng H, et al. Acc Chem Res. 2022 Mar 1;55(5):593-604. doi: 10.1021/acs.accounts.1c00598. Epub 2022 Feb 9. Acc Chem Res. 2022. PMID: 35138817 Free PMC article. Review.
We emphasize that integration with digital platforms represents an opportunity to establish and efficiently manage widespread testing, tracking, epidemiological intelligence, and data sharing backed by community participation. We highlight how digital technologies can addr …
We emphasize that integration with digital platforms represents an opportunity to establish and efficiently manage widespread testing, track …
Patient education in Mohs surgery: a review and critical evaluation of techniques.
Patel P, Malik K, Khachemoune A. Patel P, et al. Arch Dermatol Res. 2021 May;313(4):217-224. doi: 10.1007/s00403-020-02119-5. Epub 2020 Aug 12. Arch Dermatol Res. 2021. PMID: 32785836 Review.
BACKGROUND: Traditional in-person discussion alone is often used for preoperative education in Mohs micrographic surgery (MMS). The appropriate use of more modern education techniques is not well defined in the MMS literature. ...METHODS AND MATERIALS: We performed …
BACKGROUND: Traditional in-person discussion alone is often used for preoperative education in Mohs micrographic surgery (MMS). The a …
Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease.
Gaig C, Compta Y, Heidbreder A, Marti MJ, Titulaer MJ, Crijnen Y, Högl B, Lewerenz J, Erro ME, García-Moncó JC, Nigro P, Tambasco N, Patalong-Ogiewa M, Erdler M, Macher S, Berger-Sieczkowski E, Höftberger R, Geis C, Hutterer M, Milán-Tomás A, Martin-Bastida A, Manzanares LL, Quintas S, Höglinger GU, Möhn N, Schöberl F, Thaler FS, Asioli GM, Provini F, Plazzi G, Berganzo K, Blaabjerg M, Brüggemann N, Farias T, Ng CF, Giordana C, Herrero-San Martín A, Huebra L, Kotschet K, Liendl H, Montojo T, Morata C, Pérez-Pérez J, Puertas I, Seifert-Held T, Seitz C, Simabukuro MM, Téllez N, Villacieros-Álvarez J, Willekens B, Sabater L, Iranzo A, Santamaria J, Dalmau J, Graus F. Gaig C, et al. Neurology. 2021 Oct 4;97(14):e1367-e1381. doi: 10.1212/WNL.0000000000012639. Neurology. 2021. PMID: 34380749 Free PMC article.
BACKGROUND AND OBJECTIVES: Anti-IgLON5 disease is a recently described neurologic disease that shares features of autoimmunity and neurodegeneration. Abnormal movements appear to be frequent and important but have not been characterized and are underreported. ...
BACKGROUND AND OBJECTIVES: Anti-IgLON5 disease is a recently described neurologic disease that shares features of autoimmunity and ne …
194 results